Position in SKYE
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2
New position
Shares Held
4
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 3 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026GILPIN WEALTH MANAGEMENT, LLC holds $898,245 across 21 Biotechnology names. SKYE ranks #21 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OTLK |
Outlook Therapeutics, Inc.
|
555,000 | $882,450 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
302 | $5,109 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
28 | $1,538 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
16 | $1,391 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
3 | $1,115 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
9 | $1,103 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
3 | $948 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
11 | $897 |
All Filings in SKYE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2 | 4 | Shares | Sole | 2026-07-24 | |
| No filing history on record for this holder in this stock. | ||||||